Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma

Fig. 4

Correlation between the prognostic DRLs signature and clinicopathological features. (A-H). Kaplan–Meier curve for overall survival in different clinical features such as gender (A, B), age (C, D), tumor grade (E, F) and isocitrate dehydrogenase (IDH) status (G, H). (I). Kaplan–Meier curves for progression-free survival (PFS) in the high- and low-risk groups

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us